Torsten Hoppe‐Tichy

2.2k total citations
77 papers, 1.5k citations indexed

About

Torsten Hoppe‐Tichy is a scholar working on Pharmacology, Infectious Diseases and Geriatrics and Gerontology. According to data from OpenAlex, Torsten Hoppe‐Tichy has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 21 papers in Infectious Diseases and 17 papers in Geriatrics and Gerontology. Recurrent topics in Torsten Hoppe‐Tichy's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Antifungal resistance and susceptibility (14 papers). Torsten Hoppe‐Tichy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Antifungal resistance and susceptibility (14 papers). Torsten Hoppe‐Tichy collaborates with scholars based in Germany, United States and United Kingdom. Torsten Hoppe‐Tichy's co-authors include Stefanie Swoboda, Walter E. Haefeli, Markus Weigand, Christoph Lichtenstern, Heinrich K. Geiss, Thilo Bertsche, Heike von Baum, Thorsten Brenner, Gerd Mikus and Jürgen Burhenne and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Torsten Hoppe‐Tichy

72 papers receiving 1.4k citations

Peers

Countries citing papers authored by Torsten Hoppe‐Tichy

Since Specialization

Citations

This map shows the geographic impact of Torsten Hoppe‐Tichy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Hoppe‐Tichy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Hoppe‐Tichy more than expected).

Fields of papers citing papers by Torsten Hoppe‐Tichy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Hoppe‐Tichy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Hoppe‐Tichy. The network helps show where Torsten Hoppe‐Tichy may publish in the future.

Co-authorship network of co-authors of Torsten Hoppe‐Tichy

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Hoppe‐Tichy. A scholar is included among the top collaborators of Torsten Hoppe‐Tichy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Hoppe‐Tichy. Torsten Hoppe‐Tichy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections 2024 ·Antibiotics ·(unknown), Uwe Liebchen, Otto Frey, (unknown), Sabrina Klein, Torsten Hoppe‐Tichy, Matthias Karck, Anna L. Meyer, (unknown)	3
2	Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteers 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Lenka A. Taylor, (unknown), Torsten Hoppe‐Tichy, Jürgen Burhenne, Kathrin I. Foerster, Markus Dachtler, Gerald Huber, (unknown), (unknown), David Czock, Gerd Mikus, Antje Blank, Walter E. Haefeli	8
3	Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers 2022 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), Lenka A. Taylor, (unknown), Torsten Hoppe‐Tichy, Jürgen Burhenne, Kathrin I. Foerster, (unknown), (unknown), (unknown), (unknown), David Czock, Gerd Mikus, Antje Blank, Walter E. Haefeli	7
4	Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy 2022 ·Cell Death and Disease ·Li Liu, Shanshan Han, Xi Xiao, (unknown), Jury Gladkich, Ulf Hinz, Stefan Hillmer, Torsten Hoppe‐Tichy, (unknown), (unknown), Oliver Strobel, Ingrid Herr	21
5	Wie vollständig ist der Bundeseinheitliche Medikationsplan? Eine Analyse bei Krankenhausaufnahme 2020 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), (unknown), Andreas D. Meid, (unknown), Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	6
6	Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development 2019 ·JMIR Medical Informatics ·(unknown), (unknown), Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	0
7	Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach 2017 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	11
8	Association of preventable adverse drug events with inpatients' length of stay-A propensity-matched cohort study 2017 ·International Journal of Clinical Practice ·(unknown), Andreas D. Meid, (unknown), M. Thalheimer, Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	25
9	Therapeutic drug monitoring of beta-lactam antibiotics – Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Thorsten Brenner, Stefanie Swoboda, Markus Weigand, Torsten Hoppe‐Tichy	65
10	Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions 2016 ·International Journal of Clinical Pharmacy ·Hanna M. Seidling, (unknown), Torsten Hoppe‐Tichy, (unknown), Pierrick Bedouch, Pascal Bonnabry, Jamie J. Coleman, Fernando Fernández-Llimós, Christian Lovis, (unknown), (unknown), Lenka A. Taylor, Sarah Pontefract, Patricia M. L. A. van den Bemt, Heleen van der Sijs, Walter E. Haefeli	7
11	Antibiotika-Anwendung 2012/13 in 109 deutschen Akutkrankenhäusern 2015 ·DMW - Deutsche Medizinische Wochenschrift ·Winfried V. Kern, M. Fellhauer, Martin J. Hug, Torsten Hoppe‐Tichy, (unknown), Michaela Steib–Bauert, Katja de With	20
12	Patients enrolled in randomised clinical trials are not representative of critically ill patients in clinical practice: Observational study focus on tigecycline 2013 ·International Journal of Antimicrobial Agents ·Johannes B. Zimmermann, (unknown), Markus Weigand, Thomas Brückner, Eike Martin, Torsten Hoppe‐Tichy, Stefanie Swoboda	8
13	Development and evaluation of a computerised clinical decision support system for switching drugs at the interface between primary and tertiary care 2012 ·BMC Medical Informatics and Decision Making ·Markus G. Pruszydlo, (unknown), Torsten Hoppe‐Tichy, Jens Kaltschmidt, Walter E. Haefeli	17
14	Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin 2010 ·Der Anaesthesist ·Christoph Lichtenstern, Stefanie Swoboda, Markus Hirschburger, Eugen Domann, Torsten Hoppe‐Tichy, (unknown), Cornelia Lass‐Flörl, M. A. Weigand	7
15	Update: invasive Pilzinfektionen 2010 ·Der Anaesthesist ·Christoph Lichtenstern, Stefanie Swoboda, Markus Hirschburger, Eugen Domann, Torsten Hoppe‐Tichy, (unknown), Cornelia Lass‐Flörl, M. A. Weigand	5
16	Implementation of Practice Guidelines for Antifungal Therapy in a Surgical Intensive Care Unit and Its Impact on Use and Costs 2009 ·Chemotherapy ·Stefanie Swoboda, Christoph Lichtenstern, (unknown), (unknown), (unknown), (unknown), (unknown), Markus Mieth, Stefan Hofer, Hans‐Günther Sonntag, Torsten Hoppe‐Tichy, Markus Weigand	32
17	Substandard anti-malarial drugs in Burkina Faso 2008 ·Malaria Journal ·(unknown), S Diallo, Boubacar Coulibaly, (unknown), Torsten Hoppe‐Tichy, Ali Sié, Olaf Müller	53
18	Rule-based standardised switching of drugs at the interface between primary and tertiary care 2007 ·European Journal of Clinical Pharmacology ·(unknown), Thilo Bertsche, Jens Kaltschmidt, Markus G. Pruszydlo, Torsten Hoppe‐Tichy, I. Walter‐Sack, Walter E. Haefeli	11
19	A simple isocratic HPLC assay to determine linezolid concentrations in different biomatrices for in vivo and in vitro studies 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Stefanie Swoboda, (unknown), Konstantinos Anagnostakos, Heinrich K. Geiss, Markus Weigand, Torsten Hoppe‐Tichy	25
20	Tissue and serum levofloxacin concentrations in diabetic foot infection patients 2004 ·Journal of Antimicrobial Chemotherapy ·K. Oberdorfer, Stefanie Swoboda, A. Hamann, (unknown), Klaus Kusterer, Bert‐Jan H. van den Born, Torsten Hoppe‐Tichy, (unknown), Heike von Baum	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact